Insulet
PODD
#1050
Rank
S$27.73 B
Marketcap
S$394.01
Share price
-3.74%
Change (1 day)
8.93%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Operating Margin for Insulet (PODD)

Operating Margin as of December 2025 (TTM): 14.49%

According to Insulet's latest financial reports and stock price the company's current Operating Margin is 14.49%. At the end of 2024 the company had an Operating Margin of 14.49%.

Operating Margin history for Insulet from 2006 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202414.49%14.6%
202312.65%1584.25%
20220.75%-59.76%
20211.87%73.95%
20201.07%-45.4%
20191.96%112.97%
20180.92%-116.08%
2017-5.74%-21.52%
2016-7.31%-68.59%
2015-23.26%12.39%
2014-20.70%13.97%
2013-18.16%-25.68%
2012-24.44%-34.77%
2011-37.47%-40.6%
2010-63.07%-42.43%
2009-109.56%-51.33%
2008-225.11%-44.09%
2007-402.65%-57.43%
2006-945.81%-97.8%
2005-43,010.00%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
ICU Medical
ICUI
-2.77%-119.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-20.35%-240.44%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
17.57% 21.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78% 29.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
18.56% 28.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78% 15.80%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
37.87% 161.35%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.